|
FLCN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.76030309720454E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.61160000292193E-08 |
| Normal-vs-Stage2 |
8.362300E-03 |
| Normal-vs-Stage3 |
2.807700E-02 |
| Normal-vs-Stage4 |
9.837200E-01 |
| Stage1-vs-Stage2 |
6.725200E-01 |
| Stage1-vs-Stage3 |
9.249200E-01 |
| Stage1-vs-Stage4 |
6.666200E-02 |
| Stage2-vs-Stage3 |
7.924600E-01 |
| Stage2-vs-Stage4 |
1.256550E-01 |
| Stage3-vs-Stage4 |
2.000400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.2515000974721E-10 |
| Normal-vs-AfricanAmerican |
7.55319999999893E-05 |
| Normal-vs-Asian |
8.780800E-01 |
| Caucasian-vs-AfricanAmerican |
8.958800E-01 |
| Caucasian-vs-Asian |
2.056800E-01 |
| AfricanAmerican-vs-Asian |
2.407800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.61349888584095E-11 |
| Normal-vs-Female |
1.182640E-04 |
| Male-vs-Female |
9.562800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.669800E-02 |
| Normal-vs-Extreme_Weight |
1.82932999999164E-05 |
| Normal-vs-Obese |
1.03389999994707E-06 |
| Normal-vs-Extreme_Obese |
1.831510E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.844000E-01 |
| Normal_Weight-vs-Obese |
3.124800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.977590E-01 |
| Extreme_Weight-vs-Obese |
1.789840E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.336100E-02 |
| Obese-vs-Extreme_Obese |
3.190400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.226020E-02 |
| Normal-vs-Age(41-60Yrs) |
9.75208802600491E-12 |
| Normal-vs-Age(61-80Yrs) |
1.82528999999043E-05 |
| Normal-vs-Age(81-100Yrs) |
3.782800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.641800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.023000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.753600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.795400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.814100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.207600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.17890158640921E-12 |
| Normal-VS-Type2 PRCC |
2.155400E-04 |
| Normal-VS-KIRP CIMP |
4.889000E-01 |
| Normal-VS-Unclassified PRCC |
5.813200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.665800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.204620E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.784400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.636300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.153000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.790070E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.344840E-03 |
| Normal-vs-N1 |
1.138410E-02 |
| Normal-vs-N2 |
9.405200E-01 |
| N0-vs-N1 |
5.834200E-01 |
| N0-vs-N2 |
3.846200E-01 |
| N1-vs-N2 |
3.358600E-01 |
|
|
